葡萄糖皮质醇-FAS轴控制在转移性播种期间的免疫逃避
Monica Cassandras1,2, Xavier Sanchez1,2, Lauren Hsu1,2,3
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nature
|March 4, 2026
概括
在三阴性乳腺癌中,散布的瘤细胞 (DTC) 通过葡萄糖皮质体受体 (GR) 激活来逃避免疫攻击. 与免疫疗法一起抑制GR显示出减少转移和改善生存率的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症转移 癌症转移
背景情况:
- 转移是癌症死亡的主要原因,特别是在三阴性乳腺癌中.
- 散播瘤细胞 (DTC) 必须克服免疫监测以建立二次瘤.
- 早期DTCs免疫逃避的机制仍然不太清楚.
研究的目的:
- 研究DTC如何在早期转移播种过程中逃避抗瘤免疫力.
- 为了确定参与DTC免疫逃避的关键分子通路.
- 探索针对DTC免疫逃避的治疗策略.
主要方法:
- 利用了一种三阴性乳腺癌模型,具有可见抗原和相关的CD8+T细胞.
- 分析了幸存的DTC,以寻找抵抗机制.
- 使用优化的标签工具来确定关键路径.
主要成果:
- 葡萄糖皮质体受体 (GR) 激活被确定为CD8+ T细胞和DTCs中的自然杀手细胞抗性的关键驱动因素.
- GR激活抑制了FAS-FASL通路,这是对DTCs的关键细胞毒性机制.
- 药理GR抑制与免疫治疗相结合,显著降低了转移负担,并延长了小鼠的寿命.
结论:
- 在DTC中,GR激活代表了一种特定的免疫逃避机制.
- 针对GR与免疫疗法结合,提供了一种潜在的治疗策略,以消除DTCs.
- 这种方法可能会提供一种与原发性瘤疗法不同的新疗法.
相关概念视频
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
TGF - β Signaling Pathway
10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K


